Stefan Schulze
President at Vifor Pharma Management AG
Network origin in Stefan Schulze first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
26
| Non-Profit Organization | Miscellaneous Commercial Services | 26 |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland.
22
| Subsidiary | Pharmaceuticals: Major | 22 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland.
7
| Joint Venture | Pharmaceuticals: Major | 7 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Stefan Schulze via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Chairman Corporate Officer/Principal Director/Board Member | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| UCB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Sales & Marketing Chief Executive Officer President | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Public Communications Contact Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| GALENICA AG | Medical Distributors | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| RELYPSA INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| SANOFI | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| FRESENIUS MEDICAL CARE AG | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Executive Officer | |
Fresenius Medical Care Management AG
 Fresenius Medical Care Management AG Medical DistributorsDistribution Services Part of Fresenius SE & Co. KGaA, Fresenius Medical Care Management AG is a German company that provides innovative products, therapies, and services to create a livable future for their patients. The company is based in Bad Homburg, Germany. The company specializes in chronic and acute kidney dialysis and therapeutic apheresis. The company was founded in 2005. The CEO is Helen Giza. | Medical Distributors | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Executive Officer | |
OM Pharma SA
 OM Pharma SA Pharmaceuticals: MajorHealth Technology OM Pharma SA engages in manufacture of pharmaceutical products. Its portfolio includes products for respiratory tract infections, lower urinary tract infections, chronic venous insufficiency, microangiopathies, hemorrhoids, and menometrorrhagia. The company was founded by Jean-Rene Ricard in 1937 and is headquartered in Meyrin, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer | |
Fresenius Medical Care Holdings, Inc.
 Fresenius Medical Care Holdings, Inc. Medical/Nursing ServicesHealth Services Fresenius Medical Care Holdings, Inc. provides kidney dialysis services and renal care products. It offers specialty pharmacy and laboratory services as well as manufacturing and distributing dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Waltham, MA. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Director of Finance/CFO Chief Executive Officer | |
| University of Copenhagen | College/University | Doctorate Degree Doctorate Degree | |
Speedel Pharma AG
 Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Chief Executive Officer Chief Executive Officer | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Campus Holding SA
 Campus Holding SA Investment ManagersFinance Campus Holding SA, formerly Ares Life Sciences (Ares), currently trading as Waypoint Capital, was founded in 2008 by Ernesto Bertarelli to build a portfolio of revenue generating, late-stage innovative life sciences companies. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Director of Finance/CFO Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| University of Lausanne | College/University | Graduate Degree Doctorate Degree | |
| London Business School | College/University | Masters Business Admin Masters Business Admin | |
Verband Forschender Arzneimittelhersteller eV
 Verband Forschender Arzneimittelhersteller eV Miscellaneous Commercial ServicesCommercial Services Verband Forschender Arzneimittelhersteller eV, founded in 1994, is an association of researching pharmaceutical companies in Germany. The private company is based in Berlin, Germany. The German company's main focus is on the drugs and therapies currently being researched in the industry. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Masters Business Admin | |
| STALLERGENES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer | |
Esaote SpA
 Esaote SpA Medical SpecialtiesHealth Technology Esaote SpA is a holding company, which engages in the production of medical diagnostic systems. Its products include ultrasound system applications, dedicated magnetic resonance imaging (MRI) systems, healthcare information technology software applications, and interventional and mini-invasive system applications under the brand name Esaote. The company was founded by Carlo Castellano in 1982 and is headquartered in Genoa, Italy. | Medical Specialties | Director/Board Member Director/Board Member | |
| University of Aston | College/University | Doctorate Degree Undergraduate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| Wallon Institute for Life Lead Sciences | Director/Board Member Director/Board Member | ||
| BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| University of Basel | College/University | Doctorate Degree Doctorate Degree | |
| Swiss Federal Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
The Innovative Medicines Initiative
 The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Drugstore Chains | Chairman Director/Board Member | |
Actimed Therapeutics Ltd.
 Actimed Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Actimed Therapeutics Ltd. is a British clinical stage specialty pharmaceutical company that focuses on bringing innovation to the treatment of muscle wasting disorders. Actimed is based in Ascot, UK. Actimed's lead product, ACM-001 (S-pindolol), targets multiple biological pathways that drive cachexia and has generated promising proof of concept data in a phase II clinical trial in patients with non-small cell lung cancer (NSCLC) and colorectal cancer (CRC). The company is currently preparing for further clinical studies of cachexia in these two cancer types. The company was founded in 2017 by Stefan D. Anker and Andrew Justin Stewart Coats, two world-leading physicians in muscle wasting research, together with Yann Colardelle, a professional in communications and medical education. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
Opterion Health AG
 Opterion Health AG Medical/Nursing ServicesHealth Services Opterion Health AG is a Swiss company that focuses on bringing innovation to dialysis care and fostering home dialysis to improve the quality of life for patients suffering from end-stage renal disease (ESRD). Opterion Health is based in Muttenz, CH. The private company aims to increase the survival rates of people with ESRD and reduce healthcare costs. The company was founded in 2012 by Guido Grentzmann, and the CEO is Bjorn Englund. | Medical/Nursing Services | Chairman Director/Board Member | |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Bayer Pharma AG engages in the development and production of prescription drugs for the treatment of cardiovascular diseases and women's illnesses, as well as special therapy in the areas of oncology, hematology, and ophthalmology. It also offers medical equipment used in diagnostic imaging with applications in the field of radiology. The company was founded on March 9, 1965 and is headquartered in Berlin, Germany. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
| Leem | Founder Director/Board Member | ||
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Director/Board Member | |
| Scandinavian Society for Psychopharmacology | Corporate Officer/Principal |
Statistics
International
| Switzerland | 12 |
| United States | 11 |
| Germany | 8 |
| Denmark | 6 |
| France | 6 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 8 |
| Health Services | 4 |
| Commercial Services | 4 |
| Distribution Services | 3 |
Operational
| Director/Board Member | 295 |
| Corporate Officer/Principal | 173 |
| Chairman | 98 |
| Chief Executive Officer | 78 |
| Independent Dir/Board Member | 63 |
Most connected contacts
| Insiders | |
|---|---|
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Dieter Weinand | 32 |
| Joseph Jimenez | 32 |
| Marc M. P. de Garidel | 31 |
| Ian Read | 29 |
| Ulf Arne Wiinberg | 26 |
| Peter Andersen | 26 |
| David Ebsworth | 26 |
| Colin Bond | 25 |
| Stefan Oschmann | 23 |
| Franklin Maddux | 23 |
| Jacques Theurillat | 22 |
| Andreas Fibig | 21 |
| Susan Mahony | 21 |
| Etienne Jornod | 18 |
- Stock Market
- Insiders
- Stefan Schulze
- Company connections
